Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
How are advances in point-of-care testing altering the genetic testing landscape, and what does this mean for the clinical lab?
The current landscape of molecular hematopathology—and what steps clinical labs can take to stay at the forefront of the discipline
The latest developments in liquid biopsy and ctDNA testing and why they should be of interest to clinical laboratory professionals
NIH grant awarded to Metabolon is the first phase of what could be a three-year grant, according to a company official
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
AI could help pathologists manage increasing workloads amid staffing shortages—if only they take the leap.
When it comes to cyberattacks, the threat is “when,” not “if”—and labs must be prepared to mitigate, contain, and recover from breaches
The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests